Mogito Open Access Journals of Clinical Medicine(MJCM) Editorial Policy

MJCTT

Editorial Board

Publication Ethics

About MJCTT

Authors Guide

Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT)

1. Scope of Content

MJCTT welcomes a wide range of high-quality submissions, including original research articles, systematic reviews, clinical trial protocols, case studies, editorials, and brief communications. Submissions must be relevant to the scope of clinical trials and therapeutic innovation, including but not limited to:

• Interventional and observational clinical trials

• Pharmacological and non-pharmacological therapies

• Regulatory science and drug development

• Translational and personalized medicine

• Clinical trial methodology and design

• Safety, efficacy, and post-marketing surveillance

• Bioethics in clinical research

• Therapeutic advances in global health settings

2. Peer Review Process

All submissions to MJCTT undergo a double-blind peer-review process. Manuscripts are reviewed by at least two independent experts to ensure thorough and unbiased evaluation. The editorial board supervises the process to uphold objectivity, confidentiality, and timeliness.

Reviews focus on the manuscript’s scientific quality, methodological soundness, originality, ethical compliance, and relevance to clinical trials and therapeutic applications.

In case of conflicting reviewer recommendations, an additional reviewer or a senior editor will be consulted.
Authors are expected to respond to reviewer feedback and submit revised versions accordingly.

3. Authorship & Contributions

MJCTT adheres to the authorship criteria outlined by the International Committee of Medical Journal Editors (ICMJE). Each author listed must have substantially contributed to:

• The conception or design of the study

• Data collection, analysis, or interpretation

• Drafting or critically revising the manuscript

• Approving the final version for publication

All contributors must be identified, and their specific roles clearly stated. Authors must confirm responsibility for the accuracy and integrity of the work.

4. Ethical Standards

MJCTT upholds the highest standards of research and publication ethics in alignment with COPE (Committee on Publication Ethics) guidelines.

• Studies involving human or animal subjects must have prior ethics committee approval and documented informed consent.

• All authors must declare any financial or non-financial conflicts of interest.

• Plagiarism, data fabrication, or falsification will result in immediate rejection or retraction.

• Duplicate or redundant publication is strictly prohibited.

5. Open Access Policy

MJCTT is a fully open-access journal, making all published content freely available without restriction. Articles are published under the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

6. Data Transparency & Availability

Authors are encouraged to share data supporting the findings of their research. Where possible, data availability statements should be included, and datasets deposited in publicly accessible repositories unless restricted by ethical, legal, or proprietary considerations.

7. Corrections, Retractions & Expressions of Concern

MJCTT is dedicated to preserving the accuracy of the scholarly record. Corrections will be issued for honest errors, while retractions or expressions of concern will be published in cases of serious misconduct or methodological flaws. Such notices will be clearly marked and linked to the original publication.

8. Editorial Independence

All editorial decisions at MJCTT are made independently of commercial interests or institutional affiliations. Editors and peer reviewers are selected based on subject matter expertise and professional integrity. The journal does not accept advertisements or sponsorships that may compromise editorial standards.

9. Appeals & Complaints

Authors who wish to appeal editorial decisions must submit a detailed explanation, which will be reviewed by a senior editor or appeals committee. Ethical concerns or complaints should be submitted to the Editor-in-Chief and will be investigated in accordance with COPE procedures.

10. Indexing and Archiving

MJCTT is actively pursuing indexing in prominent scholarly databases such as DOAJ, Scopus, and PubMed Central to enhance discoverability, citation, and long-term digital preservation of published content.

Contact

For queries related to editorial policies:
Email: editors_mjctt@mogitojournal.org
Website: [mogitojournals.org]

About (MJCTT)

Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT) is a peer-reviewed, international, open access journal committed to advancing research in clinical trials, experimental therapeutics, and evidence-based medical innovation. As a key title under the Medicine & Clinical Research category of the Mogito Open Access Journals platform, MJCTT serves as a global forum for academics, clinicians, and industry experts to share high-impact, original findings and critical evaluations that shape the future of therapeutic strategies and patient care.